I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Similar documents
GUIDELINES ON PROSTATE CANCER

A schematic of the rectal probe in contact with the prostate is show in this diagram.

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

GUIDELINEs ON PROSTATE CANCER

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Collaborative Staging

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009

Chapter 2. Understanding My Diagnosis

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Prostate Case Scenario 1

LYMPHATIC DRAINAGE IN THE HEAD & NECK

ADENOCARCINOMA OF THE PROSTATE

Improved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template

TOPICS FOR DISCUSSION

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES

Localized at a focus, central point or locus. Localized finding distinct from neighboring tissues, not a threedimensional

Diffusion Weighted Imaging in Prostate Cancer

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Prognostic factors of genitourinary tumors: Do we have to care?

Neoplasms of the Prostate and Bladder

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Carcinoma of the Urinary Bladder Histopathology

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

SEER Summary Stage Still Here!

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Multiparametric Prostate MRI: PI-RADS V.2

Magnetic resonance imaging predictors of extracapsular extension of prostate cancer: Do they accurately reflect pt3 staging?

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Prostate Cancer: Screening, Treatment, and Survivorship

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

IMAGING GUIDELINES - COLORECTAL CANCER

PI-RADS V2 IN PRACTICE A PICTORIAL REVIEW

Diagnosis of prostate cancer

Staging and Treatment Update for Gynecologic Malignancies

Magnetic Resonance Imaging in the management of prostate cancer: What the Radiologists need to know?

A215- Urinary bladder cancer tissues

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

Prostate Cancer Imaging :What the Urologist Needs to Know

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Clinical Prostate Cancer Imaging

UICC TNM 8 th Edition Errata

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

Prostate Cancer. Diagnosis and Treatment. September 2016 Saskatchewan Prostate Assessment Pathway

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

OASIS 1.2T: MULTIPARAMETRIC MRI OF PROSTATE CANCER

The accuracy of prostate biopsy to assign patients with low-grade prostate cancer to active surveillance

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Definition of Synoptic Reporting

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Guidelines for Assigning Summary Stage 2000

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Prostate Overview Quiz

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)

Case Scenario 1: Thyroid

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER

GUIDELINES ON RENAL CELL CANCER

11/21/13 CEA: 1.7 WNL

MR imaging and MR spectroscopic imaging of prostate cancer

UICC TNM 8 th Edition Errata

Diagnosis and Classification of Prostate Cancer

H&E, IHC anti- Cytokeratin

Luis Ramos Harvard Medical School BIDMC Department of Radiology Class of 2011

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

Introduction. Growths in the prostate can be benign (not cancer) or malignant (cancer).

Prostate Cancer NCCN GUIDELINES FOR PATIENTS. Available online at NCCN.org/patients. Please complete. our online survey at. NCCN.org/patients/survey

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

GUIDELINES ON PENILE CANCER

REVIEW. Patterns of recurrence of bladder carcinoma following radical cystectomy

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

da Vinci Prostatectomy

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

Supplemental Information

Thyroid and Adrenal Gland

Transcription:

Prostate t Cancer MR Report

Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product in my presentation.

T N M MR Report Location in the gland Right, Left, Bilateral Apex, Mid gland, Base Extracapsular extension Neurovascular bundle invasion Seminal vesicle invasion Adjacent organs Lymph node metastasis Bone metastasis t Prostate size in three dimensions Periprostatic vessels Useful term: Organ confined disease

MR Report Location in the gland European Consensus Meeting Recommendations Dickinson L et al. European Urology 59 (2011) 477-494 Divide prostate into multiple regions 16 regions 27 regions Each region is assigned a number

Prostate Cancer - Anatomy Imaging Anatomic % glandular %of tissue prostate cancer in the gland Central Transition 5% 25% Central 20% 5% Peripheral Peripheral 75% 70% Fibromuscular Fibromuscular 0% 0% Stroma Stroma

A A B B C C Vikas Kundra M D Ph D

Prostate - Anatomy Central zone Urethra Peripheral zone Prostate coil T2-weighted MR

Prostate - Anatomy Prostate Neurovascular bundle at 5 and 7 o clock Prostate t coil T1-weighted MR

Prostate Cancer - Staging Based on Tumor-Node-Metastasis (TNM) system (T) Primary Tumour Early tumors are not well staged dby imaging: i Tumor confined dto gland TX. Cannot be assessed T0. None T1. Clinically inapparent by palpation or imaging Incidentally noted tumor T1a. in < 5% of histologic specimen T1b. in >5% of histologic i specimen Tumor sought T1c. Tumour identified by needle biopsy (e.g., because of elevated PSA) MR becomes important T2. Clinically apparent T2a. <1/2 of a lobe T2b. >1/2 of a lobe, but not both lobes T2c. Both lobes involved (TNM online 2005 by John Wiley & Sons, Inc.)

T2 Prostate Carcinoma involving i the left mid gland T2 T1

T2 Prostate Carcinoma left mid gland PZ and CZ T2 ADC

Multifocal Prostate Cancer T1 T2 T2 T2

Prostate Cancer - Staging Based on Tumor-Node-Metastasis (TNM) system (T) Primary Tumour Better staged by imaging (MR and CT) T3. Tumour extends through hthe prostatic capsule T3a. Extracapsular extension T3b. Seminal vesicle(s) invasion T4. Invasion of adjacent structures other than seminal vesicles bladder neck, external sphincter, rectum, levator muscles, or pelvic wall (TNM online 2005 by John Wiley & Sons, Inc.)

Focal prostate carcinoma on the right with bl bulge and capsular irregularity i at left lfapex Periprostatic vessels T2 T1

Neurovascular Bundle Invasion

Seminal Vesicle Invasion

Biopsy related hemorrhage is hyperintense on T1 and hypointense on T2. Hemorrhage can mask an underlying tumor in the prostate and seminal vesicles. T1 T2

T4 Prostate Carcinoma T1 T2

Prostate Cancer - Staging (N) Regional Lymph Nodes (MR and CT) NX. Cannot be assessed N0. None N1. Regional lymph node metastasis (external iliac, internal iliac, and presacral chains) (M) Distant Metastasis (Bone scan, MR and CT) MX. Cannot be assessed M0. None M1. Distant metastasis present M1a. Non-regional lymph node(s) (not in true pelvis, includes common iliac and para-aortic) aortic) Up to 50% of nodal metasasis are para-aortic without concurrent pelvic nodal metasasis suggests hematogenous spread and suggests imaging of the abdomen for staging M1b. Bone(s) M1c. Other locations (TNM online 2005 by John Wiley & Sons, Inc.)

Lymph Node Metastasis N1 M1a

Osseous Metastasis M1

T N M MR Report Location in the gland Right, Left, Bilateral Apex, Mid gland, Base Extracapsular extension Neurovascular bundle invasion Seminal vesicle invasion Adjacent organs Lymph node metastasis Bone metastasis t Prostate size in three dimensions Periprostatic vessels Useful term: Organ confined disease

Thank you